# OnCo record nai-kong-cheung (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/nai-kong-cheung/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "nai-kong-cheung" ;
  schema:name "Nai-Kong V. Cheung"@en ;
  schema:description "Developed the anti-GD2 antibodies 3F8 and naxitamab that treat relapsed neuroblastoma."@en ;
  schema:url <https://onco.cc/people/nai-kong-cheung/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Cheung%20NK%5BAuthor%5D%20neuroblastoma%20GD2> ;
  onco:tag "paediatric", "neuroblastoma", "immunotherapy" ;
  schema:jobTitle "Enid A. Haupt Chair in Pediatric Oncology, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/naxitamab-201/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .